Drug carrier pellet production process
OwnerEva Lynenskjold, Lone Norgaard Jorgenseninventors
Life of this patent
Estimating the term…
Abstract
The invention provides a process for the production of drug carrier pellets comprising spay-drying a solution of a physiologically tolerable cellulosic binder containing a physiologically tolerable inert particulate carrier having a particle size D(v, 0.5) of less than 50 μm.
Claims21
A process for the production of drug carrier pellets comprising spray-drying a solution of a physiologically tolerable cellulosic binder, containing a physiologically tolerable inert particulate carrier having a particle size D (v, 0.5) of less than 50 μm, and a filler selected from lactose, lactose monohydrate, sucrose, fructose, a fructooligosaccharide, insulin, mannitol, sorbitol, xylitol, inositol, isomalt or maltodextrin.
Spray-dried pellets comprising a physiologically tolerable cellulosic binder, a physiologically tolerable inert particulate carrier having a particle size D(v, 0.5) of less than 50 μm and a filler selected from lactose, lactose monohydrate, sucrose, fructose, fructooligosaccharides, insulin, mannitol, sorbitol, xylitol, inositol, isomalt and maltodextrin.
Dependencies are inferred from the claim text.